Hereditary Breast and Ovarian Cancer Syndrome: Genes, Risk and Testing
Understand HBOC, BRCA1/2 and other genes, inheritance, counselling, test choices and why a negative BRCA result may not exclude hereditary risk.
Written byTeam Oncquest
DJ
Reviewer
Reviewer profile
Dr. Jasmine Kaur
Dr. Jasmine Kaur is a Consultant in R&D in the Molecular Biology and Genomics Department at Oncquest Laboratories.
10
Articles reviewedof 11 in the library
4
Topics coveredAcross published contributions
Oct 202026
Latest article updatePublished content
About
Background
Dr. Jasmine Kaur is a Consultant in R&D in the Molecular Biology and Genomics Department at Oncquest Laboratories. She holds a PhD in Biotechnology from Jamia Hamdard, New Delhi, and an MPhil, with more than seven years of post-PhD experience in molecular diagnostics. Her work includes developing, standardising and validating clinically relevant molecular assays and analysing genomic biomarkers for medical testing.
Topics covered
Review record
Reviewed Articles 10
2 articles in the selected topic.
BRCA1 vs BRCA2 Mutations: Cancer Risks and Test Results
Understand BRCA1 and BRCA2, germline versus somatic findings, pathogenic variants, VUS results and genetic counselling in India.
Written byTeam Oncquest